- Home
- DRIO vs RDI Comparison
DRIO vs RDI Comparison
Compare DRIO & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- RDI
- Stock Information
- Founded
- DRIO 2011
- RDI 1937
- Country
- DRIO United States
- RDI United States
- Employees
- DRIO N/A
- RDI N/A
- Industry
- DRIO Medical/Dental Instruments
- RDI Movies/Entertainment
- Sector
- DRIO Health Care
- RDI Consumer Discretionary
- Exchange
- DRIO Nasdaq
- RDI Nasdaq
- Market Cap
- DRIO 28.3M
- RDI 30.1M
- IPO Year
- DRIO N/A
- RDI N/A
- Fundamental
- Price
- DRIO $0.66
- RDI $1.37
- Analyst Decision
- DRIO Strong Buy
- RDI Hold
- Analyst Count
- DRIO 1
- RDI 1
- Target Price
- DRIO $2.00
- RDI $2.40
- AVG Volume (30 Days)
- DRIO 199.1K
- RDI 33.3K
- Earning Date
- DRIO 05-14-2025
- RDI 05-23-2025
- Dividend Yield
- DRIO N/A
- RDI N/A
- EPS Growth
- DRIO N/A
- RDI N/A
- EPS
- DRIO N/A
- RDI N/A
- Revenue
- DRIO $28,034,000.00
- RDI $210,527,000.00
- Revenue This Year
- DRIO $22.41
- RDI $9.74
- Revenue Next Year
- DRIO $19.97
- RDI $6.39
- P/E Ratio
- DRIO N/A
- RDI N/A
- Revenue Growth
- DRIO 32.86
- RDI N/A
- 52 Week Low
- DRIO $0.50
- RDI $1.17
- 52 Week High
- DRIO $1.93
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- DRIO 43.91
- RDI 55.03
- Support Level
- DRIO $0.68
- RDI $1.34
- Resistance Level
- DRIO $0.78
- RDI $1.30
- Average True Range (ATR)
- DRIO 0.06
- RDI 0.07
- MACD
- DRIO -0.01
- RDI 0.01
- Stochastic Oscillator
- DRIO 12.63
- RDI 60.87
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.